High-Dose Rate Brachytherapy: Clinical Trials

4 trials of High-Dose Rate Brachytherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting, 1 unknown. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Active not recruiting 1, Completed 1, Recruiting 1, Unknown 1

Follow High-Dose Rate Brachytherapy: new trials by email Literature Review of High-Dose Rate Brachytherapy trials Research Report on High-Dose Rate Brachytherapy

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
Hypofractionated Radiation Therapy, Conventional Fractionated Radiotherapy, Cisplatin - Cervical Cancer, Cervix Cancer
Phase 2RecruitingUganda Cancer Institute2782026-03-112026-03-27
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer
High-Dose Rate Brachytherapy, Quality-of-Life Assessment, Questionnaire Administration - Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8
Phase 2Active not recruitingRutgers, The State University of New Jersey142019-07-172025-09-17
Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Nimotuzumab, Cisplatin, external-beam radiation - Neoplasms, Cervical Adenosquamous Cell Carcinoma
Phase 2UnknownZhujiang Hospital1002018-03-202018-08-13
Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery
Accelerated Partial Breast Irradiation, High-Dose Rate Brachytherapy, Questionnaire Administration - Ductal Breast Carcinoma In Situ, Estrogen Receptor Positive
Phase 2CompletedRutgers, The State University of New Jersey2002015-07-152023-05-15

Conditions studied

Uterine Cervical Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Uterine Cervical Dysplasia (1)

Sponsors

Rutgers, The State University of New Jersey (2)  ·  Uganda Cancer Institute (1)  ·  Zhujiang Hospital (1)

Countries

United States (2)  ·  China (1)  ·  Uganda (1)

Top investigators

Bruce Haffty, MD (1)  ·  Lara Hathout (1)  ·  Solomon Kibudde, MBChB, MMed. (1)

Results publications

PMID 30611839

NIH funding

D43TW009759 (1), P30CA072720 (1)